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Summary
Sudden cardiac death (SCD) is by definition unexpected
and cardiac in nature. The investigation is almost invari-
ably performed by a forensic pathologist. Under these cir-
cumstances the role of the forensic pathologist is twofold:
(1.) to determine rapidly and efficiently the cause and man-
ner of death and (2.) to initiate a multidisciplinary process
in order to prevent further deaths in existing family mem-
bers. If the death is determined to be due to “natural”
causes the district attorney in charge often refuses further
examinations. However, additional examinations, i.e. ex-
tensive histopathological investigations and/or molecular
genetic analyses, are necessary in many cases to clarify the
cause of death. The Swiss Society of Legal Medicine cre-
ated a multidisciplinary working group together with clin-
ical and molecular geneticists and cardiologists in the hope
of harmonising the approach to investigate SCD. The aim
of this paper is to close the gap between the Swiss recom-
mendations for routine forensic post-mortem cardiac exam-
ination and clinical recommendations for genetic testing of
inherited cardiac diseases; this is in order to optimise the
diagnostic procedures and preventive measures for living
family members.
The key points of the recommendations are (1.) the forensic
autopsy procedure for all SCD victims under 40 years of
age, (2.) the collection and storage of adequate samples for
genetic testing, (3.) communication with the families, and
(4.) a multidisciplinary approach including cardiogenetic
counselling.
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Introduction
Sudden cardiac death (SCD) is a major public health issue
worldwide. The exact incidence of sudden death in the
younger population remains unclear and the published in-
cidences are generally thought to be underestimated [1–4].
No exact data exist for Switzerland concerning the incid-
ence of SCD in the young or for the autopsy rate. The pre-
sumed values were recently published for the canton of
Vaud by Hofer et al. [5]. According to this study, the pre-
sumed incidence of SCD in the young (aged 5–39 years) is
1.71/100,000 person-years (2.73 for men and 0.69 for wo-
men). However, it might be higher as not all possible cases
of SCD (unexplained deaths, drowning, traffic accidents,
etc.) are included. The autopsy rate of sudden deaths clas-
sified as “diseases of the circulatory system” was evaluated
at 47.5% and is low compared with other countries [5].
In Switzerland, most autopsies of SCD victims are per-
formed in forensic centres. Although the majority of cases
are middle aged individuals who died from ischaemic heart
disease, there are SCDs of children and young adults who
died from genetically determined cardiac pathologies such
as cardiomyopathies and channelopathies, from the literat-
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ure data [6–9]. Therefore, the autopsy diagnosis is very im-
portant for living family members.
Despite clinical recommendations on genetic testing, the
management of SCD victims and their families remains
problematic [10–12]. The availability, or lack, of proband
DNA was identified as the flow-limiting step in the UK
[11, 13]. The current international recommendations on
genetic testing for cardiomyopathies and channelopathies
established by experts from Heart Rhythm Society, the
European Heart Rhythm Association and European Society
of Cardiology [14, 15] do not address practical aspects for
our Swiss practice during forensic autopsy, nor the issues
surrounding cardiogenetic counselling of the family mem-
bers, which is very important for the prevention and poten-
tial treatment of disease.
In order to improve the diagnosis and management of ge-
netically determined cardiac deaths, and the diagnostic pro-
cedures and preventive measures for living family mem-
bers, the working group of forensic pathologists and as-
sociated cardiologists, clinical and molecular geneticists
looked into the decision making process for the SCD
autopsy guidelines. The multidisciplinary working group
strove to provide recommendations on the interdisciplinary
collaboration and workflow for forensic SCD cases in
Switzerland, based on the existing guidelines for autopsy
practice and genetic testing for the channelopathies and
cardiomyopathies [14–18], considering the legal frame-
work of forensic activity.
Aetiology of sudden cardiac death
The most commonly detected disease in SCD victims over
35 years of age is coronary artery disease (CAD) [6, 19].
In the younger population of less than 35 years of age, car-
diomyopathies or a morphologically normal heart are the
Figure 1
Flowchart of the recommended actions after a sudden cardiac
death (SCD) and forensic autopsy. Even if an autopsy is not
performed, cardiogenetic counselling is advised after a presumed
SCD. More explanations in” Recommended course of action in
Swiss practice for SCD”
DA = district attorney
most frequent findings. According to epidemiological data
from the general population, approximately 80% of SCD
cases are attributed [15] to CAD, whereas 10–15% res-
ult from cardiomyopathies with a morphological substrate,
such as hypertrophic cardiomyopathy (HCM), dilated car-
diomyopathy (DCM), arrhythmogenic right ventricular
cardiomyopathy (ARVC), non-compaction cardiomy-
opathy (NCCM), or myocardial infiltrative diseases. For
the remaining 5–10% the cause of SCD is related either
to a structurally abnormal congenital cardiac condition (i.e.
coronary artery abnormalities) or to arrhythmias without
any structural changes, including many genetic arrhythmi-
as such as channelopathies [6].
A detailed autopsy and histopathological examination of
the heart may identify CAD or structural cardiac disease
and is best performed for all cases of SCD, especially in the
young, by or in conjunction with an expert cardiac patho-
logist [16, 18, 20]. Not all causes of SCD can be determ-
ined at autopsy. “Autopsy-negative SCD” corresponds to
cases where (1.) the autopsy failed to identify the cause of
death and (2.) non-cardiac aetiologies were excluded (e.g.,
drug overdose by toxicological analyses). The percentage
of hearts without morphological substrate found in SCD
victims varies from 6% to 53% [7–9].
Some genetically determined cardiac diseases responsible
for sudden cardiac death are characterized by morpholo-
gical alterations that may be observed at autopsy and/or
upon histopathological examination, for example, HCM,
DCM, ARVC or NCCM [18, 21–23]. Those related to
cardiac channelopathies, such as congenital long QT syn-
drome (LQTS), Brugada syndrome (BrS) or catecholam-
inergic polymorphic ventricular tachycardia (CPVT) can
be diagnosed only after molecular genetic analyses [7, 12,
24–26]. Most of these genetic disorders are characterised
by a wide genetic heterogeneity and follow an autosomal
dominant mode of inheritance [14, 27–29] (table 1).
Current situation of sudden cardiac death
management in Switzerland
In Switzerland, as in many other countries, SCDs and all
other sudden unexpected deaths (SUDs) must be reported
to the district attorney’s (DA’s) office, which in turn seizes
the corpse and initiates an inquiry. The main focus of such
an inquest is to determine the manner of death (natural,
accidental, suicidal or homicidal). Since 1 January 2011,
Swiss Criminal Procedure Code has been harmonised
throughout Switzerland. The DA commissions forensic
pathologists to conduct the examination of the body. In
Switzerland, the preliminary forensic examination is a
scene investigation, a thorough external examination of the
corpse, ideally at the scene, performed by specially trained
physicians who evaluate the findings at the scene and the
medical history. If third-party involvement is excluded, the
DA will often refrain from commissioning further examin-
ations, such as an autopsy. For example, for elderly indi-
viduals with no signs of relevant trauma and/or a medical
history which could explain the cause of death, the corpse
would be liberated after an external examination and not
be subjected to an autopsy. As younger individuals often
do not have a medical history that could reasonably ex-
plain their death, the DA usually commissions a forensic
Review article Swiss Med Wkly. 2015;145:w14129
Swiss Medical Weekly · PDF of the online version · www.smw.ch Page 2 of 6
autopsy. The main focus of the forensic autopsy, which
does not require the consent of the next-of-kin, is to find
out under what circumstances the person died and to re-
construct the course of events that led to the individual’s
demise. The actual cause of death is legally of minor im-
portance. Many forensic pathologists will refrain from per-
forming histopathological or toxicological examinations if
a natural death, such as an acute coronary artery occlusion
with resulting myocardial infarction, is detected. In some
cases, a genetic test is required in order to reach a final
forensic autopsy diagnosis, and as such may be requested
by the DA [30, 31]. However, genetic testing during the
course of autopsy is rarely performed as (1.) medical dia-
gnostics are not a priority for the DA, (2.) costs of genetic
analysis would be supported by the DA and (3.) the feed-
back of results to the next-of-kin raises several ethical is-
sues. In practice, the DA will mostly refrain from commis-
sioning post-mortem molecular testing.
Although all SUDs must, by law, be reported to the DA,
this is not always the case. Owing to lack of knowledge
and/or fear of judicial issues, the death-certifying physician
will occasionally deem a sudden death to be “natural”
rather than “undetermined”. Such cases may, however, un-
dergo a clinical autopsy if the next-of-kin wish it. The
main focus of a clinical autopsy, performed by a clinical
pathologist, is to determine the cause of death and identify
any pathological disorders. Unfortunately, many cases will
not undergo any further post mortem examinations and
are subsequently buried or cremated. The percentage of
non-autopsied cases of young victims of presumed SCD in
Switzerland is unknown and could be high. Nevertheless,
in cases of suspected inheritable cardiac disorder, cardio-
genetic counselling should be suggested.
The Swiss protocols for forensic post-mortem cardiac ex-
amination have been rather inconsistent. In order to unify
the different autopsy techniques and to improve the general
standard of SCD case handling, the Swiss Society of Legal
Medicine (SSLM) founded a working group to establish re-
commendations for minimum standards of autopsy prac-
tice for cardiac examination. These recommendations were
published on the SSLM homepage: harmonisation of
routine forensic autopsy practice for SCD cases in Switzer-
land [32]. There are currently several different definitions
of sudden cardiac death. This paper is restricted to the ter-
minology used in forensic pathology in Switzerland (table
2), which defines SCD as a sudden unexpected death
(SUD) of cardiac causes occurring in a short time period
(generally within 1 hour after symptom onset) in a person
with known or unknown cardiac disease. Sudden infant
death syndrome (SIDS) is a subgroup of unexplained sud-
den death among infants under one year of age. SIDS lies
beyond the scope of these recommendations.
Recommended course of action in
Swiss forensic practice for sudden
death
In order to optimise the diagnostic procedures and the pre-
ventive measures for the family members, we recommend
the following procedure (see also fig. 1).
Table 1: Spectrum of the most frequent inherited cardiomyopathies and ion channel disorders (channelopathies) associated with sudden cardiac death.
Disorder Inheritance Number of known
genes
Yield of the genetic
test
Cardiomyopathies
Hypertrophic cardiomyopathy Usually AD ~ 30 60%
Arrhythmogenic right ventricular cardiomyopathy Usually AD/AR 12 50%
Dilated cardiomyopathy Usually AD ~ 40 10–40%
Left ventricular non-compaction cardiomyopathy AD > 10 15–20%
Channelopathies
Long QT syndrome AD/AR 15 70%
Brugada syndrome AD 21 15–30%
Catecholaminergic polymorphic ventricular tachycardia AD/AR 6 50–60%
Short QT syndrome AD/AR 5 5–10%
AD = autosomal dominant; AR = autosomal recessive
Table 2: Terms, abbreviations and definitions used in Swiss forensic pathology (in alphabetical order).
Term Abbreviation Definition
Cause of death COD Clinical condition that led to death
Clinical autopsy Autopsy performed upon the request of the treating physicians and/or family
members, with the main focus on the cause of death. Permission from family
compulsory.
District attorney DA Prosecutor
Forensic autopsy Autopsy commissioned by the DA with the main focus on legal issues. Permission
from the relatives not necessary.
Genetic heterogeneity Mutations in genes that cause the same or different disorders
Manner of death MOD Circumstances that led to death
Sudden cardiac death SCD Unexpected death due to cardiac causes
Sudden infant death syndrome SIDS Unexpected, to date not fully understood, infant death
Sudden unexpected death SUD Sudden unexpected/unexplained death; all violent or unexpected deaths, regardless
of their cause
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Autopsy
The post-mortem heart examination should be performed
in accordance with the guidelines given by the SSLM [31]
for all cases of SCD under 40 years of age. If no mor-
phological (macroscopic and microscopic) or toxicological
cause of death can be established, and biochemical ana-
lyses do not show any significant disorder, a so-called “un-
determined” or “functional death” can be postulated (also
termed, in our opinion erroneously, “negative autopsy”).
A “functional death” may be due to, for example, an ar-
rhythmic disorder or an epileptic seizure. A “functional
death” usually indicates that the forensic pathologist could
not find any structural/morphological substrate as the cause
of death.
In the autopsy report of SUD cases, and also in cases where
a genetically determined cardiomyopathy is diagnosed by
morphological examination (HCM, ARVC, DCM,
NCCM), the possibility for genetic testing should be men-
tioned and the appropriate samples should be collected in
anticipation of such testing. The DA should be asked for
permission to store the collected samples for 5 years. The
examiner should note, providing the DA permitted stor-
age of the samples for 5 years, the following: “in addition
to sample storage for toxicological analyses etc., samples
were collected for possible genetic testing. These addi-
tional samples will be stored for 5 years.” These samples,
namely EDTA blood or tissue, should be stored at least at
–20 °C (ideally at –80 °C), initially in the laboratory of
forensic medicine. The samples can then be sent to an ac-
credited laboratory for genetic analysis with the agreement
of the DA, who has the authority to do so. In the case of
a suspected inherited cardiac disorder, the victim’s family
should be informed that the results of the autopsy may be
of clinical importance to them.
Multidisciplinary cardiogenetic counselling and
information
If the relatives contact the forensic pathologist for more in-
formation or request the results of the autopsy, multidiscip-
linary counselling should be organised if an inherited car-
diac disorder is suspected, and if wished for, initiated by
the forensic pathologist. The way to contact the family is
discussed with the local ethics committee (for example in
Lausanne a succinct letter addressed to the family is sent
through the DA; this solution allows the right not be in-
formed to be respected). The forensic pathologist is encour-
aged to attend this multidisciplinary cardiogenetic coun-
selling, which would involve at least a cardiologist and a
clinical geneticist. This consultation should be performed
in accordance to established international guidelines [14,
16]; ethical and Swiss legal frameworks must be respected
[31]. The information concerning the autopsy results, the
risk of a genetic disease and further examinations, such as a
post-mortem genetic testing of the deceased should be dis-
cussed during this multidisciplinary counselling.
In our opinion, the proposed course of action should allow
the gap to be closed between existing Swiss recommend-
ations for routine forensic cardiac examination [32] and
the clinical recommendations such as “HRS/EHRA Expert
Consensus Statement on the State of Genetic Testing for
the Channelopathies and Cardiomyopathies” [14] as well.
Synchronisation of autopsy standards with multidisciplin-
ary cardiogenetic counselling will improve the manage-
ment of these rare but complex cases and the diagnostic and
potential therapeutic procedures for the living family mem-
bers.
Key points
1. The autopsy of sudden death victims under 40 years of
age is strongly recommended.
2. Frozen (at least –20 °C, ideally –80 °C) post-mortem
material for possible genetic testing (EDTA blood and/
or tissue) should be collected and stored for at least 5
years upon permission from the DA.
3. The family should be informed about the autopsy
results.
4. Multidisciplinary cardiogenetic counselling for the
family of a SCD victim with a suspected inheritable
cardiac disorder is recommended.
5. The recommended time to perform post-mortem genetic
testing is after a cardiogenetic counselling of the
family.
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Figures (large format)
Figure 1
Flowchart of the recommended actions after a sudden cardiac death (SCD) and forensic autopsy. Even if an autopsy is not performed,
cardiogenetic counselling is advised after a presumed SCD. More explanations in” Recommended course of action in Swiss practice for SCD”
DA = district attorney
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